Literature DB >> 15599307

Engraftment potential of human amnion and chorion cells derived from term placenta.

Marco Bailo1, Maddalena Soncini, Elsa Vertua, Patrizia Bonassi Signoroni, Silvia Sanzone, Guerino Lombardi, Davide Arienti, Francesca Calamani, Daniela Zatti, Petra Paul, Alberto Albertini, Fausto Zorzi, Angelo Cavagnini, Fabio Candotti, Georg S Wengler, Ornella Parolini.   

Abstract

BACKGROUND: Fetal membranes are tissues of particular interest for several reasons, including their role in preventing rejection of the fetus and their early embryologic origin. which may entail progenitor potential. The immunologic reactivity and the transplantation potential of amnion and chorion cells, however, remain to be elucidated.
METHODS: Amnion and chorion cells were isolated from human term placenta and characterized by immunohistochemistry, flow cytometric analysis, and expression profile of relevant genes. The immunomodulatory characteristics of these cells were studied in allogeneic and xenogeneic mixed lymphocyte reactions and their engraftment potential analyzed by transplantation into neonatal swine and rats. Posttransplant chimerism was determined by polymerase chain reaction analysis with probes specific for human DNA.
RESULTS: Phenotypic and gene expression studies indicated mesenchymal stem cell-like profiles in both amnion and chorion cells that were positive for neuronal, pulmonary, adhesion, and migration markers. In addition, cells isolated both from amnion and chorion did not induce allogeneic nor xenogeneic lymphocyte proliferation responses and were able to actively suppress lymphocyte responsiveness. Transplantation in neonatal swine and rats resulted in human microchimerism in various organs and tissues.
CONCLUSIONS: Human amnion and chorion cells from term placenta can successfully engraft neonatal swine and rats. These results may be explained by the peculiar immunologic characteristics and mesenchymal stem cell-like phenotype of these cells. These findings suggest that amnion and chorion cells may represent an advantageous source of progenitor cells with potential applications in a variety of cell therapy and transplantation procedures.

Entities:  

Mesh:

Year:  2004        PMID: 15599307     DOI: 10.1097/01.tp.0000144606.84234.49

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  102 in total

1.  Osteogenic differentiation of human amniotic epithelial cells and its application in alveolar defect restoration.

Authors:  Si Jiawen; Zhang Jianjun; Dai Jiewen; Yu Dedong; Yu Hongbo; Shi Jun; Wang Xudong; Steve G F Shen; Guo Lihe
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

2.  Expression of transcriptional factor genes (Oct-4, Nanog, and Sox-2) and embryonic stem cell-like characters in placental membrane of Buffalo (Bubalus bubalis).

Authors:  Kapil Dev; Shiv Kumar Giri; Anil Kumar; Anita Yadav; Birbal Singh; Sanjeev Kumar Gautam
Journal:  J Membr Biol       Date:  2012-04-22       Impact factor: 1.843

Review 3.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

4.  Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro.

Authors:  H Karlsson; T Erkers; S Nava; S Ruhm; M Westgren; O Ringdén
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

5.  Placenta-derived stem cells: new hope for cell therapy?

Authors:  Marco Evangelista; Maddalena Soncini; Ornella Parolini
Journal:  Cytotechnology       Date:  2008-09-28       Impact factor: 2.058

6.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

7.  Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).

Authors:  O Parolini; F Alviano; A G Betz; D W Bianchi; C Götherström; U Manuelpillai; A L Mellor; R Ofir; P Ponsaerts; S A Scherjon; M L Weiss; S Wolbank; K J Wood; C V Borlongan
Journal:  Placenta       Date:  2011-05-14       Impact factor: 3.481

Review 8.  Placental-derived stem cells: Culture, differentiation and challenges.

Authors:  Maira S Oliveira; João B Barreto-Filho
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

Review 9.  Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review.

Authors:  Nadim Srour; Bernard Thébaud
Journal:  Stem Cells Transl Med       Date:  2015-10-22       Impact factor: 6.940

Review 10.  Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy.

Authors:  Chad D Markert; Anthony Atala; Jennifer K Cann; George Christ; Mark Furth; Fabrisia Ambrosio; Martin K Childers
Journal:  PM R       Date:  2009-06       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.